172 related articles for article (PubMed ID: 34355654)
1. Pan-PI3Ki targets multiple B-ALL microenvironment interactions that fuel systemic and CNS relapse.
Ridge SM; Whiteley AE; Yao H; Price TT; Brockman ML; Murray AS; Simon BG; Islam P; Sipkins DA
Leuk Lymphoma; 2021 Nov; 62(11):2690-2702. PubMed ID: 34355654
[TBL] [Abstract][Full Text] [Related]
2. [Adult acute lymphoblastic leukemia with central nervous system involvement: an overview].
Thomas X; Pavan L; Le QH
Bull Cancer; 2008; 95(7):707-15. PubMed ID: 18755650
[TBL] [Abstract][Full Text] [Related]
3. [Central nervous system involvement in acute lymphoblastic leukemia].
Yao H
Rinsho Ketsueki; 2019; 60(9):1212-1220. PubMed ID: 31597846
[TBL] [Abstract][Full Text] [Related]
4. Hypofractionated moderate dose radiation, intrathecal chemotherapy, and repetitive reinduction/reconsolidation systemic therapy for central nervous system relapse of acute lymphoblastic leukemia in children.
Belasco JB; Goldwein JW; Simms S; Griffin G; D'Angio G; Lange B
Med Pediatr Oncol; 2000 Feb; 34(2):125-31. PubMed ID: 10657874
[TBL] [Abstract][Full Text] [Related]
5. Central nervous system relapse in adults with acute lymphoblastic leukemia.
Surapaneni UR; Cortes JE; Thomas D; O'Brien S; Giles FJ; Koller C; Faderl S; Kantarjian H
Cancer; 2002 Feb; 94(3):773-9. PubMed ID: 11857312
[TBL] [Abstract][Full Text] [Related]
6. The value of high-dose systemic chemotherapy and intrathecal therapy for central nervous system prophylaxis in different risk groups of adult acute lymphoblastic leukemia.
Cortes J; O'Brien SM; Pierce S; Keating MJ; Freireich EJ; Kantarjian HM
Blood; 1995 Sep; 86(6):2091-7. PubMed ID: 7662956
[TBL] [Abstract][Full Text] [Related]
7. Leukaemia hijacks a neural mechanism to invade the central nervous system.
Yao H; Price TT; Cantelli G; Ngo B; Warner MJ; Olivere L; Ridge SM; Jablonski EM; Therrien J; Tannheimer S; McCall CM; Chenn A; Sipkins DA
Nature; 2018 Aug; 560(7716):55-60. PubMed ID: 30022166
[TBL] [Abstract][Full Text] [Related]
8. Improvement in CNS protective treatment in non-high-risk childhood acute lymphoblastic leukemia: report from the Japanese Children's Cancer and Leukemia Study Group.
Tsurusawa M; Katano N; Yamamoto Y; Hirota T; Koizumi S; Watanabe A; Takeda T; Hatae Y; Yatabe M; Mimaya J; Gushiken T; Nishi K; Anami K; Kikuta A; Kanegane H; Asami K; Nishikawa K; Sekine I; Kawano Y; Iwai A; Furuyama T; Ijichi O; Miyake M; Mugishima H; Fujimoto T
Med Pediatr Oncol; 1999 Apr; 32(4):259-6. PubMed ID: 10102019
[TBL] [Abstract][Full Text] [Related]
9. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
Hales EC; Taub JW; Matherly LH
Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
[TBL] [Abstract][Full Text] [Related]
10. Central nervous system involvement in acute lymphoblastic leukemia is mediated by vascular endothelial growth factor.
Münch V; Trentin L; Herzig J; Demir S; Seyfried F; Kraus JM; Kestler HA; Köhler R; Barth TFE; Te Kronnie G; Debatin KM; Meyer LH
Blood; 2017 Aug; 130(5):643-654. PubMed ID: 28550041
[TBL] [Abstract][Full Text] [Related]
11. Central nervous system recurrence in adult patients with acute lymphoblastic leukemia: frequency and prognosis in 467 patients without cranial irradiation for prophylaxis.
Sancho JM; Ribera JM; Oriol A; Hernandez-Rivas JM; Rivas C; Bethencourt C; Parody R; Deben G; Bello JL; Feliu E;
Cancer; 2006 Jun; 106(12):2540-6. PubMed ID: 16700036
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous targeting of PI3Kδ and a PI3Kδ-dependent MEK1/2-Erk1/2 pathway for therapy in pediatric B-cell acute lymphoblastic leukemia.
Wang X; Zhang X; Li BS; Zhai X; Yang Z; Ding LX; Wang H; Liang C; Zhu W; Ding J; Meng LH
Oncotarget; 2014 Nov; 5(21):10732-44. PubMed ID: 25313141
[TBL] [Abstract][Full Text] [Related]
13. The prognosis and survival of childhood acute lymphoblastic leukemia with central nervous system relapse.
Unal S; Yetgin S; Cetin M; Gümrük F; Arslan D; Ozyürek E; Tuncer M; Topçu M
Pediatr Hematol Oncol; 2004; 21(3):279-89. PubMed ID: 15202168
[TBL] [Abstract][Full Text] [Related]
14. Central nervous system involvement in adult acute lymphoblastic leukemia.
Thomas X; Le QH
Hematology; 2008 Oct; 13(5):293-302. PubMed ID: 18854093
[TBL] [Abstract][Full Text] [Related]
15. Central nervous system disease in hematologic malignancies: historical perspective and practical applications.
Pui CH; Thiel E
Semin Oncol; 2009 Aug; 36(4 Suppl 2):S2-S16. PubMed ID: 19660680
[TBL] [Abstract][Full Text] [Related]
16. Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis and/or at first relapse: results from the GET-LALA group.
Reman O; Pigneux A; Huguet F; Vey N; Delannoy A; Fegueux N; de Botton S; Stamatoullas A; Tournilhac O; Buzyn A; Charrin C; Boucheix C; Gabert J; Lhéritier V; Vernant JP; Fière D; Dombret H; Thomas X;
Leuk Res; 2008 Nov; 32(11):1741-50. PubMed ID: 18508120
[TBL] [Abstract][Full Text] [Related]
17. High VLA-4 expression is associated with adverse outcome and distinct gene expression changes in childhood B-cell precursor acute lymphoblastic leukemia at first relapse.
Shalapour S; Hof J; Kirschner-Schwabe R; Bastian L; Eckert C; Prada J; Henze G; von Stackelberg A; Seeger K
Haematologica; 2011 Nov; 96(11):1627-35. PubMed ID: 21828124
[TBL] [Abstract][Full Text] [Related]
18. Prophylaxis and therapy of central nervous system involvement in adult acute lymphoblastic leukemia: recommendations of the Polish Adult Leukemia Group.
Giebel S; Krawczyk-Kuliś M; Adamczyk-Cioch M; Czyz A; Lech-Marańda E; Piatkowska-Jakubas B; Paluszewska M; Pałynyczko G; Piszcz J; Hołowiecki J;
Pol Arch Med Wewn; 2008 Jun; 118(6):356-61. PubMed ID: 18619191
[TBL] [Abstract][Full Text] [Related]
19. Effect of combined treatment with a pan-PI3K inhibitor or an isoform-specific PI3K inhibitor and everolimus on cell proliferation in GH-secreting pituitary tumour in an experimental setting.
Pivonello C; Patalano R; Solari D; Auriemma RS; Frio F; Vitulli F; Grasso LFS; Di Cera M; De Martino MC; Cavallo LM; Cappabianca P; Colao A; Pivonello R
Endocrine; 2018 Dec; 62(3):663-680. PubMed ID: 30066286
[TBL] [Abstract][Full Text] [Related]
20. The role of craniospinal irradiation in adults with a central nervous system recurrence of leukemia.
Sanders KE; Ha CS; Cortes-Franco JE; Koller CA; Kantarjian HM; Cox JD
Cancer; 2004 May; 100(10):2176-80. PubMed ID: 15139061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]